@FiercePharma: PDI expects $57M from deal to market 'newly FDA approved drug'. Vivus diet pill Qsymia, maybe? Release | Follow @FiercePharma
> Baxter International ($BAX) posted a 7.5% increase in second-quarter profits, as sales grew slightly to $3.6 billion. Report
> Novartis sued Sun Pharmaceutical Industries to block the Indian genericsmaker's version of the osteoporosis drugs Zometa and Reclast, which together brought in more than $2 billion in 2011 sales. News
> Under a federal judge's ruling, Johnson & Johnson ($JNJ) won't have to fight consumer claims stemming from the quality problems and recalls within its consumer drug division. Report
> Baxter International won FDA approval for a new dosage strength of its hemophilia drug Advate. Report
> Actelion managed to post a profit for the first half of this year, thanks to cost-cutting efforts that outweighed a decline in Tracleer sales. Report
> SkyePharma invested £5 million ($7.8 million) to help build a facilty for the manufacture of Sanofi's Flutiform. Report
> Somaxon settled another patent fight over its sleep drug Silenor, this time with Cadila Healthcare and Zydus Pharma. Release
Biotech News
@FierceBiotech: Study: Low-income patients less likely to join cancer trials. Report | Follow @FierceBiotech
@JohnCFierce: Interesting approach--super high risk; EnVivo grabs Alzheimer's spotlight with promising PhIIb results. News | Follow @JohnCFierce
@RyanMFierce: Innovation in pharma manufacturing is under-appreciated. Thinking about this as I cover Novartis' woes at Lincoln, NE plant. Hurt Q2 sales. | Follow @RyanMFierce
> Faded star at Pfizer leads to discounted $68M IPO for Durata. Article
> Infinity restructures drug deal, raises $27.5M as it scrambles to refocus. News
> Multibillion-dollar R&D strategy is paying off for Novartis. More
@FierceMedDev: Medtronic appears to be negotiating with Indian device giant Trivitron Healthcare for a "strategic investment." More | Follow @FierceMedDev
@MarkHFierce: U.K. Sanofi site draws $7.8M investment for asthma inhaler production. Item | Follow @MarkHFierce
@DamianFierce: Quest Dx and LabCorp are scaling back expectations after a tepid Q2. More | Follow @DamianFierce
> Slow market stunts growth of Quest, LabCorp. Report
> Medtronic reportedly eyes stake in India's Trivitron Healthcare. News
> Weaker euro batters Stryker's Q2 earnings. Article
Pharma Manufacturing News
> Novartis's Q2 sales hit after Excedrin production woes. News
> Sanofi plant adds 40 to produce SkyePharma product. More
> Docs reportedly get smuggled cancer drugs in Pakistan bazaar. Story
> J&J 'decree' upgrades cost 200 jobs in Puerto Rico. Article
CRO News
> Medpace adds clinical pharma unit for PhI trials. Story
> ScinoPharm will manufacture blockbuster hopeful Qsymia. Article
> Europe moves toward liberalizing clinical trial rules. More
> Study: Low-income patients less likely to join cancer trials. Report
> Indian regulators shutter 12 drug plants over enviro concerns. News
Vaccines News
> Galena stock jumps with NeuVax patent. Report
> Oral vax rides on advanced microparticles. News
> Silk could eliminate 'cold chain' need. Story
> MedImmune to cut 200 jobs, layoffs hit vax R&D. Article
> University of Birmingham explores attitudes toward polio vax in India. More
> HIV-positive patients approved for smallpox vax in an emergency. Item
And Finally... Sitting around all day isn't just making you unhealthy. It might also be making you dumber. Report